Last $43.44 USD
Change Today +0.30 / 0.70%
Volume 473.9K
CPHD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas L. Gutshall

Co-Founder, Director and Member of Nominating & Governance Committee, Cepheid
AgeTotal Calculated CompensationThis person is connected to 32 board members in 3 different organizations across 5 different industries.

See Board Relationships
76$195,102

Background*

Mr. Thomas L. Gutshall is a Co-founder of Cepheid and served as its Chief Executive Officer from August 1996 to April 2002. Mr. Gutshall has more than 35 years of experience in specialty chemicals, pharmaceuticals and diagnostics. He served as a Consultant to CV Therapeutics Inc. from September 1996 to December 2002 and served as its President and Chief Operating Officer from January 1995 to September 1996. Mr. Gutshall served in executive level positions with Syntex ...

Read Full Background

Corporate Headquarters*

904 Caribbean Drive
Sunnyvale, California 94089

United States

Phone: 408-541-4191
Fax: 408-541-4192

Board Members Memberships*

Former Director
Director
Director
1994-N/A
Former Chairman of Nominating & Governance Committee, Chairman of Nominating & Governance Committee, Director and Member of Audit Committee
1996-Present
Co-Founder, Director and Member of Nominating & Governance Committee

Education*

BS
University of Delaware

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$55,833
Total Calculated Compensation$195,102
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CPHD:US $43.44 USD +0.30

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William J. Welch M.B.A.Chief Executive Officer, President and Director
Sequenom Inc.
$400.0K
Hany Massarany Chief Executive Officer, President and Director
GenMark Diagnostics, Inc.
$450.0K
Douglas C. Bryant Chief Executive Officer, President and Director
Quidel Corp.
$509.1K
John A. Kraeutler Chief Executive Officer and Director
Meridian Bioscience, Inc.
$901.4K
Patrick J. Balthrop Sr.Chief Executive Officer, President, Director, Member of Executive Committee and Member of Strategy & Development Committee
Luminex Corporation
$700.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CEPHEID INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.